Effect of Jackfruit Consumption on Adipokine, Cerebral Response, Cognitive Performance and Anthropometric Parameters in Boxers
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Salivary Irisin Level
研究概览
简要总结
This study investigates the effects of jackfruit oil extract on adipokine levels (Irisin, Omentin-1), brain-derived neurotrophic factor (BDNF), cognitive performance, and body measurements in healthy young boxers aged 18-25. Participants were randomly assigned to four groups receiving different doses of jackfruit oil extract (0, 100, 200, 300 mg/kg) or no supplement. Saliva samples, cognitive tests, and body measurements were collected at the start of the study and after 30 days to evaluate the outcomes.
详细描述
This interventional study evaluates the effects of different doses of jackfruit oil extract on healthy young boxers aged 18-25. Participants were randomly assigned to four groups and followed for 30 days.
Saliva samples were collected to measure irisin, omentin-1, and BDNF levels. Cognitive performance was assessed using the Wisconsin Card Sorting Test and the Trail Making Test. Anthropometric parameters including weight, BMI, waist, hip, chest, limb circumferences, and body composition were measured at baseline and on day 30.
Statistical analyses were performed using SPSS version 26. ANOVA, Duncan, and Pearson correlation tests were used to determine significant differences and relationships between variables.
This study is randomized and controlled. Participants receive either one of three doses of jackfruit oil extract or no supplement. The follow-up period is 30 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 25 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male boxers aged 18-25 years
- •Healthy individuals without any diagnosed chronic disease
- •Participating in regular weekly boxing training
- •Able to continue training throughout the study period
- •Willing to voluntarily participate in the study
- •Able to provide written and/or verbal informed consent
排除标准
- •Presence of chronic diseases (e.g., diabetes, cardiovascular disorders)
- •Any injury or musculoskeletal condition preventing continuation of training
- •Known allergy or hypersensitivity to jackfruit or its components
- •Use of medications or supplements that could interfere with study outcomes
- •Individuals who refuse to provide informed consent
结局指标
主要结局
Salivary Irisin Level
时间窗: Day 0 and Day 30
Irisin levels measured from saliva samples collected from participants using the ELISA method.
Salivary Omentin-1 Level
时间窗: Day 0 and Day 30.
Omentin-1 levels measured from saliva samples collected from participants using the ELISA method.
Salivary BDNF Level
时间窗: Day 0 and Day 30.
BDNF levels measured from saliva samples collected from participants using the ELISA method.
次要结局
- Body Weight (kg)(Day 0 and Day 30)
- Height (cm)(Day 0 and Day 30)
- Body Mass Index (kg/m²)(Day 0 and Day 30)
- Waist Circumference (cm)(Day 0 and Day 30)
- Hip Circumference (cm)(Day 0 and Day 30)
- Chest Circumference (cm)(Day 0 and Day 30)
- Upper Arm Circumference (Right/Left, cm)(Day 0 and Day 30)
- Wrist Circumference (Right/Left, cm)(Day 0 and Day 30)
- Thigh Circumference (Right/Left, cm)(Day 0 and Day 30)
- Calf Circumference (Right/Left, cm)(Day 0 and Day 30)
- Total Body Fat Mass (kg)(Day 0 and Day 30)
- Total Body Fat Percentage (%)(Day 0 and Day 30)
- Abdominal Fat Mass (kg)(Day 0 and Day 30)
- Regional Fat Percentages (Right/Left Arm & Leg)(Day 0 and Day 30)
- Total Muscle Mass (kg)(Day 0 and Day 30)
- Regional Muscle Mass (Right/Left Arm & Leg, kg)(Day 0 and Day 30)
- Basal Metabolic Rate (BMR)(Day 0 and Day 30)
- Metabolic Age(Day 0 and Day 30)
- Total Body Water (kg)(Day 0 and Day 30)
- Total Body Water Percentage (%)(Day 0 and Day 30)
- WCST Total Correct Responses(Day 0 and Day 30)
- WCST Total Incorrect Responses(Day 0 and Day 30)
- WCST Perseverative Error Count(Day 0 and Day 30)
- WCST Total Time (seconds)(Day 0 and Day 30)
- Trail Making Test A Completion Time (seconds)(Day 0 and Day 30)
- Trail Making Test B Completion Time (seconds)(Day 0 and Day 30)
- Biomarker Correlations (Irisin-Omentin-BDNF vs. Dose/Day)(Based on Day 30 measurements)
- Safety Outcomes (Adverse Event Monitoring)(Continuous monitoring throughout 30 days)
研究者
HATİCE BUDAK
Researcher / Principal Investigator/ Master's Student
Bayburt University